Extended prenatal survival of a non-mosaic trisomy 22 with aneuploid cytotrophoblasts [3]

Prenatal Diagnosis

Volumn 21, Issue 10, 2001, Pages 897-899

  Hengstschlger, Markus ^a   Bettelheim, Dieter ^a   Rosner, Margit ^a   Repa, Christa ^a   Deutinger, Josef ^a   Bernaschek, Gerhard ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; CHROMOSOME MOSAICISM; CYTOTROPHOBLAST; HUMAN; LETTER; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SURVIVAL; TRISOMY; TRISOMY 22;

ADULT; ANEUPLOIDY; CHROMOSOMES, HUMAN, PAIR 22; FEMALE; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; PREGNANCY; TRISOMY; TROPHOBLASTS; ULTRASONOGRAPHY, PRENATAL;

EID: 0035169170     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.154     Document Type: Letter

References (6)

1. Clinical and molecular studies in full trisomy 22: Further delineation of the phenotype and review of the literature. Reply to Dr Robinson and Dr Kalousek
2. Clinical and molecular studies in full trisomy 22: Further delineation of the phenotype and review of the literature
3. Placental mosaicism and intrauterine survival of trisomies 13 and 18
4. Mosaicism most likely accounts for extended survival of trisomy 22
5. Maternal uniparental disomy 22 has no impact on the phenotype